# "Performance of HPV DNA Test in Presence of Co-infection With Common RTIs"

> **NCT02830230** · NA · UNKNOWN · sponsor: **Tata Memorial Hospital** · enrollment: 508 (estimated)

## Conditions studied

- Cervical Inflammation and Human Papilloma Virus Performance

## Interventions

- **DRUG:** Tab cefixime,Tab Azithromycin

## Key facts

- **NCT ID:** NCT02830230
- **Lead sponsor:** Tata Memorial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2017-12
- **Final completion:** 2018-07
- **Target enrollment:** 508 (ESTIMATED)
- **Last updated:** 2016-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02830230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02830230, ""Performance of HPV DNA Test in Presence of Co-infection With Common RTIs"". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02830230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*